Repurposed drug may boost liver transplant success
An existing drug could protect donor livers from damage during the transplantation process and reduce complications that occur afterwards, a study suggests.
Dec 21, 2022
0
31
An existing drug could protect donor livers from damage during the transplantation process and reduce complications that occur afterwards, a study suggests.
Dec 21, 2022
0
31
Under-fire Dutch medical device maker Philips said Wednesday extensive testing on its recalled respirator devices showed they were "within safety limits" for use, but that a final verdict rests with global regulatory authorities.
Dec 21, 2022
0
2
Researchers at the University of Tokyo have used artificial DNA to target and kill cancer cells in a completely new way. The method was effective in lab tests against human cervical cancer- and breast cancer-derived cells, ...
Dec 21, 2022
0
78
Cambridge scientists have managed to identify and kill those breast cancer cells that evade standard treatments in a study in mice. The approach is a step towards the development of new treatments to prevent relapse in patients.
Dec 20, 2022
0
14
Fatigue is a common and potentially debilitating side effect of cancer radiation therapy.
Dec 20, 2022
0
71
A new study published by experts in Singapore suggests that an artificial intelligence (AI) platform that identifies patient-specific drug combinations can help those whose lymphomas have relapsed.
Dec 16, 2022
0
36
It's tempting to follow the latest trend when it comes to health care, but for patients who live with heart failure, some alternative treatments could have serious consequences.
Dec 13, 2022
0
8
The ongoing COVID-19 pandemic, caused by the SARS-CoV-2 virus, has been devastating the entire world. While the vaccination program is advancing, drug treatments for COVID-19 are still highly important for those who become ...
Dec 9, 2022
0
81
The use of circulating tumor cell (CTC) count to guide the choice between chemotherapy and endocrine therapy as first-line therapy for patients with metastatic, estrogen receptor (ER)-positive/HER2-negative breast cancer ...
Dec 8, 2022
0
2
A large-scale new study offers a new approach to treating in type 2 diabetes, one that puts patients in charge of their own medication. The Trimaster study is the first to allow people with type 2 diabetes to choose their ...
Dec 7, 2022
0
29